Esophageal Neoplasms: all 1,631 studies
Page 5 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation TherapyRecruitingNCT04846309Phase 1
- Neoadjuvant Treatment Modalities in Esophageal CancerRecruitingNCT04821843Phase 3
- Chemoradiotherapy in Esophageal or Esophagogastric Junction CancerRecruitingNCT04821778Phase 3
- Endoscopic Resection of Gastrointestinal NeoplasmsRecruitingNCT04780256
- Fluorescence Image Guided Foregut SurgeryRecruitingNCT04734821Not applicable
- Development of a Clinical Decision Support System With Artificial Intelligence for Cancer CareRecruitingNCT04675138
- Resilience and Equity in Aging, Cancer, and Health (REACH)RecruitingNCT04674267Not applicable
- Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction CancerRecruitingNCT04660760Phase 2
- Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)RecruitingNCT04654975
- Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy .RecruitingNCT04652180Not applicable
- A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal CancerNot yet recruitingNCT04616040
- Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal CancerRecruitingNCT04576858
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesAvailableNCT04566393
- Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During RadiotherapyRecruitingNCT04517019Not applicable
- Total Intravenous Anesthesia and Recurrence Free SurvivalRecruitingNCT04513808Phase 3
- High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in ObesityRecruitingNCT04500392Not applicable
- CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1RecruitingNCT04455282
- Study of Larotinib in Unresectable Advanced or Recurrent Esophageal CancerRecruitingNCT04415853Phase 3
- A Study of Sigvotatug Vedotin in Advanced Solid TumorsRecruitingNCT04389632Phase 1
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
- RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).RecruitingNCT04306458Not applicable
- Chemoradiotherapy in Unresectable Esophageal CancerRecruitingNCT04278287Phase 1/2
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersRecruitingNCT04221893Not applicable
- EsophaCap for the Detection of Early Esophageal CarcinomaRecruitingNCT04214119
- Serial MRI Scans During Radiation TherapyRecruitingNCT04188535Not applicable
- Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-LinacRecruitingNCT04172753Not applicable
- Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell CarcinomaRecruitingNCT04135664Phase 3
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruitingNCT04075305
- Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal CancerRecruitingNCT04018872Phase 2
- Non-invasive Testing for Early oEesophageal Cancer and DysplasiaRecruitingNCT04001478
- Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversRecruitingNCT03948100Not applicable
- APG-2449 in Patients With Advanced Solid TumorsRecruitingNCT03917043Phase 1
- Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung CancerRecruitingNCT03908671Not applicable
- Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal CarcinomaRecruitingNCT03790553Phase 3
- Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsRecruitingNCT03740256Phase 1
- Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer PatientsRecruitingNCT03731442Phase 3
- Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal CancerRecruitingNCT03712774
- Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer SurgeryRecruitingNCT03587532Not applicable
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaRecruitingNCT03556228Phase 1/2
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowRecruitingNCT03551951
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsRecruitingNCT03526835Phase 1/2
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc ResectionRecruitingNCT03427346Not applicable
- Organoid Based Response Prediction in Esophageal CancerRecruitingNCT03283527
- Distribution of Lymph Node Metastases in Esophageal CarcinomaRecruitingNCT03222895
- Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal AdenocarcinomaRecruitingNCT03222635Not applicable
- Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerRecruitingNCT03161522Phase 2
- Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal CancerRecruitingNCT03094884Phase 1
- Prediction Model of Response for CCRT in Esophageal CancerRecruitingNCT03081988
- MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing ChemoradiotherapyRecruitingNCT02988921Not applicable
- Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal CancerRecruitingNCT02972372Not applicable
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersRecruitingNCT02838836
- Chemoradiotherapy in Elderly Patients With Oesophagus CancerRecruitingNCT02735057Phase 1/2
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal CancersRecruitingNCT02584244Phase 1/2
- Mayo Clinic Upper Digestive Disease SurveyRecruitingNCT02530983
- Tissue Collection Protocol for Gastroesophageal CancersRecruitingNCT02495337
- Standard Follow-Up Program (SFP) for Patients With Esophageal CancerRecruitingNCT02454790
- University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer BiorepositoryEnrolling by invitationNCT02427269
- Chemoradiotherapy for Advanced Esophageal CancerRecruitingNCT02297217Phase 2
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Proton Therapy for Esophageal CancerRecruitingNCT01684904Not applicable
- Clinical & Pathological Studies of Upper Gastrointestinal CarcinomaRecruitingNCT01048281
- Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruitingNCT00991094
- Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersRecruitingNCT00900419
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruitingNCT00899626
- Genetic Determinants of Barrett's Esophagus and Esophageal AdenocarcinomaRecruitingNCT00288119
- Esophageal Cancer Risk RegistryRecruitingNCT00260585
- Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of LifeRecruitingNCT00260559
- Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung LiningRecruitingNCT00242723
- Evaluations of Alcohol Warning LabelsCompletedNCT06129487Not applicableResults posted
- NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursTerminatedNCT05714553Phase 1/2Results posted
- A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid TumorsTerminatedNCT05572684Phase 1/2Results posted
- Niraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsTerminatedNCT05169437Phase 2Results posted
- A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTerminatedNCT05070247Phase 1/2Results posted
- MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)CompletedNCT05007106Phase 2Results posted
- A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal CancerTerminatedNCT04945733Phase 2Results posted
- ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2)TerminatedNCT04752358Phase 2Results posted
- Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract TumorsTerminatedNCT04683939Phase 1/2Results posted
- A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal CarcinomaCompletedNCT04540211Phase 3Results posted
- Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX ChemotherapyCompletedNCT04526886Not applicableResults posted
- A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative ResectionTerminatedNCT04510285Phase 2Results posted
- Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal CancerCompletedNCT04505553Phase 2Results posted
- Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal CancerCompletedNCT04499924Phase 2/3Results posted
- Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal CancersActive, not recruitingNCT04430738Phase 2Results posted
- Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction AdenocarcinomaTerminatedNCT04260191Phase 1Results posted
- A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Active, not recruitingNCT04225117Phase 2Results posted
- Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) AdenocarcinomaCompletedNCT04097028Phase 2Results posted
- Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck CancerCompletedNCT03993353Phase 2Results posted
- Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension StudyCompletedNCT03933449Phase 3Results posted
- Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal AdenocarcinomasCompletedNCT03783936Phase 2Results posted
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction CarcinomaCompletedNCT03777657Phase 3Results posted
- Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family MembersCompletedNCT03611309Not applicableResults posted
- Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal CancerCompletedNCT03529669Not applicableResults posted
- Proton Beam Therapy in the Treatment of Esophageal CancerTerminatedNCT03482791Not applicableResults posted
- Rapid Assessment of Esophageal Adenocarcinoma Risk TestTerminatedNCT03366012Not applicableResults posted
- KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric CancerCompletedNCT03342937Phase 2Results posted
- Endoesophageal Brachytherapy for Patients With Esophageal CancerCompletedNCT03335813Not applicableResults posted
- FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction AdenocarcinomaCompletedNCT03283761Phase 2Results posted
- A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)TerminatedNCT03281369Phase 1/2Results posted
- A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsCompletedNCT03261947Phase 2Results posted